Import Bl­F Therapeutic Apparatus — Buy in Bulk from Supplier in China

The BL-F Therapeutic Apparatus from Hubei Bluelight Science & Technology Development Co., Ltd. is a seventh-generation device positioned for diabetes management support through non-invasive therapeutic application. The apparatus employs phototherapy-based technology delivered via a user interface designed for patient self-operation in both clinical and home environments. Its portable form factor allows use outside medical facilities, though the specific wavelength, intensity output and treatment protocol duration are not stated in the listing and require direct supplier confirmation.

The device construction emphasises lightweight materials and compact dimensions for patient mobility between treatment locations. Safety compliance is referenced against international health regulations, though no specific standards (such as IEC 60601-1 for medical electrical equipment or ISO 13485 for quality management) are named in the source material. The therapeutic mechanism, described as Bluelight therapy, requires clarification on whether it operates in the blue light spectrum (approximately 450-495nm) or uses this as a proprietary branding term for a different modality entirely.

Healthcare distributors, clinic procurement officers and medical device importers represent the intended buyer segments. The apparatus is marketed for hospitals, clinics and personal healthcare settings. Importers must verify with Hubei Bluelight Science & Technology Development Co., Ltd. the device's regulatory classification in their target market, as diabetes treatment claims may trigger medical device registration requirements, clinical evidence demands, or prescription status depending on jurisdiction.

Hubei Bluelight Science & Technology Development Co., Ltd. is located at the Hubei Science and Education Building, 2 Hongshan Road, Wuhan, Hubei Province, China. The company holds an imported supplier tier and harbour trust tier on the platform, with a 0.00% response rate and zero average response hours recorded. Buyers should establish direct communication channels outside platform messaging given these engagement metrics.

The supplier presents itself as a developer of therapeutic technology across seven product generations. No manufacturing facility details, quality system certifications, or regulatory approvals are stated in the available profile. The Wuhan location places the company within a major Chinese medical and scientific research hub, though this does not independently confirm clinical validation or manufacturing compliance with international medical device standards.